5,8,8A,9-TETRAHYDRO-5-(4-HYDROXY-3,5-DIMETHOXYPHENYL)-9-METHOXY-FURO(3',4':6,7)NAPHTHO(2,3-D)-1,3-DIOXOL-6(5AH)-ONE, (5R-(5.ALPHA.,5A.BETA.,8A.ALPHA.,9.BETA.))-
UNII UY5BXI2HZ5
Substance Identification & Data
This profile provides standardized clinical and technical data for 5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-9-methoxy-furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5ah)-one, (5r-(5.alpha.,5a.beta.,8a.alpha.,9.beta.))-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) UY5BXI2HZ5.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 118356-05-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H22O8 AMTKNUDRCUERFP-DXRQPORESA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-9-methoxy-furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5ah)-one, (5r-(5.alpha.,5a.beta.,8a.alpha.,9.beta.))-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.